Leerink Partners Starts Neurocrine Bio. (NBIX) at Market Perform
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $165.11 +6.63%
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Leerink Partners analyst Marc Goodman initiates coverage on Neurocrine Bio. (NASDAQ: NBIX) with a Market Perform rating and a price target of $110.00.
For an analyst ratings summary and ratings history on Neurocrine Bio. click here. For more ratings news on Neurocrine Bio. click here.
Shares of Neurocrine Bio. closed at $105.41 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Neurocrine to present two-year CRENESSITY data at medical meeting
- Bernstein SocGen Group Starts Cipher Mining (CIFR) at Outperform
- Goldman Sachs Upgrades Plains All American (PAA) to Neutral
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
